Norway market view
Norway biotech and pharma directory
Norwegian biotech, pharma, and diagnostics companies — 15+ hand-reviewed profiles. The Oslo region hosts Bayer Pharma's manufacturing site, Nykode (formerly Vaccibody) oncology immunotherapies, Photocure (oncology diagnostics), and Targovax. Trondheim hosts ArcticZymes with a marine-derived enzyme portfolio.
In-depth analysis
Read the related market brief
Deep-dive editorial map of this region’s operators, capabilities, partnerships, and regulatory landscape.
Full list
Regional records
No records in this region match the current filter set.
No records match the current filter set.
No matching record found
We could not find a public record that matches the current filter set. Try a broader search or submit a company for review.
No records in this region match the current filter set.
Norway — a specialist oncology + vaccine layer.
Oslo anchors Bayer Pharma, Vaccibody/Nykode (cancer immunotherapies), Photocure (oncology diagnostics), Targovax. Trondheim adds ArcticZymes — marine-biotech-derived enzymes.
This page surfaces Norway's niche operators.
Use it when evaluating oncology immunotherapies, computational biology, or specialised marine-origin enzymes.
Frequently asked questions
Questions about norway biotech and pharma directory
How many biotech companies are in Norway?
The Memel Biotech directory lists 15+ verified Norwegian biotech, pharma, and CDMO companies.
What are the major Norwegian biotech operators?
Bayer Pharma Oslo (manufacturing), Nykode/Vaccibody (cancer immunotherapies), Photocure (oncology diagnostics), Targovax, ArcticZymes Trondheim (marine-derived enzymes).
What is Norway known for in biotech?
Norway's biotech base is smaller than Sweden's or Denmark's but distinctly specialised — oncology immunotherapy, vaccine platforms, and marine-biotech enzymes. The University of Oslo and NTNU Trondheim anchor academic supply.
Next step
Compare Norway with Finland or Sweden.
Move into Finland (diagnostics, instruments) or Sweden (AstraZeneca, BioArctic) for a wider Nordic context.